top of page

Biotech veteran Harvey Berger on why he joined Kojin Therapeutics

Harvey Berger describes the science of ferroptosis and his experience working with Kojin's scientific founder Stuart Schreiber. He also shares a few memories of the beginnings of the biotech sector.




Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page